Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Annals of Oncology, 06/04/09
Neyns B et al. - Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG. A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.
Related Articles
Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT
Journal of Neuro-Oncology, 10/30/09
Relevance Score: 68%
A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09
Relevance Score: 66%
Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09
Relevance Score: 66%
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Neuro-Oncology, 10/05/09
Relevance Score: 66%
Data Presented On Oncophage Cancer Vaccine In Recurrent Glioma At SNO 2009
Antigenics, 10/30/09
Relevance Score: 65%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/01/09
Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinsons disease
Parkinsonism & Related Disorders, 12/01/09
Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review
Seizure - European Journal of Epilepsy, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


